How to taper off GLP-1 medication

There is no universal taper schedule, and what is right for you depends on your dose, how long you have been on the medication, your goal, your other conditions, and your prescriber. The pattern below is illustrative. It is the kind of thing that shows up in real-world endocrinology practice and patient communities, not a clinical guideline. Bring it to your clinician as a starting point for a conversation, not as a plan.

A common pattern looks like this. Hold your current dose for a few weeks while you write down your maintenance plan: protein target, training schedule, weighing cadence, and a personal weight threshold for restarting. Step down one dose and hold for another three to four weeks while you watch hunger, weight, and protein. Step down again toward a lower dose and hold again. Then either stop, or, if hunger and weight are still steady, hold there as a maintenance dose. The whole process from full dose to stopped takes most people roughly two to four months.

The specifics vary by medication. Semaglutide steps commonly run 2.4, 1.7, 1.0, 0.5, and 0.25 milligrams weekly; tirzepatide commonly 15, 12.5, 10, 7.5, 5, and 2.5 milligrams weekly. Holding at a lower dose for longer is generally better tolerated than rushing the step-down. Some people skip a dose they were never titrated through. None of this is a substitute for a conversation with your prescriber, who has your history and can adjust based on how you respond.

Appetite tends to return first. Many people notice it in the second or third week off the medication, sometimes earlier if you stopped from a low dose, sometimes later if you tapered slowly. The first signal is usually a meal that does not feel as satisfying as it used to, or a snack you would have skipped a month ago suddenly looking interesting. That is normal. It is the suppression fading, not a failure of willpower.

Food noise tends to come back over weeks, not hours. The mental chatter about food, the planning of the next meal, the cravings that show up unbidden, was quiet on the drug. It returns gradually, often building around weeks four to eight, then settling into a baseline that depends on your habits, sleep, stress, and whether you are in a calorie deficit.

Weight can bounce in the first couple of weeks even before any real fat regain. Some of that is water. GLP-1s slow gastric emptying, so your gut holds less when the drug is gone, and stored glycogen rebinds water as you eat more carbs. A two to four pound bounce is common and not real fat. Real regain, if it happens, builds slowly across the next several months.

Fasting glucose may rise, especially in people who took a GLP-1 for type 2 diabetes or prediabetes. This is the metabolic effect of the drug fading, not a new problem. GI side effects, the nausea, constipation, or reflux some people had on the drug, usually fade within a couple of weeks. Everyone responds differently, so use this as a rough map and bring anything that concerns you to your clinician.

A few patterns matter more than any single number. Weight rebound speed: a slow drift of half a pound a week is often water and usually not a worry; a steady two pounds a week for several weeks is a clearer signal. Hunger: a daily one-to-five hunger note on the same scale at the same time, averaged across the week, often catches climbing hunger a week or two earlier than the scale will. Sleep: short sleep can raise hunger hormones, and the maintenance window is the worst time to be running on six hours. Food noise and mood: notice whether food is taking up more mental space than it did a month ago, since that is often the earliest sign something is drifting.

These are the kinds of patterns Phaze's Taper Coach is built to surface. It looks at your logged weight, hunger, protein, and sleep and shows a quiet, plain-language note when one of them turns, more like a careful friend who actually reads your numbers than an alarm. Seeing protein, sleep, hunger, and weight on one screen makes it easier to connect a change today to a habit that slipped a couple of weeks ago, so you can act on the cause rather than chase the symptom. It informs your own decisions and the conversation with your clinician; it does not make medical decisions for you.

Both are reasonable. The published data on cycling and maintenance dosing is thin, because trials were designed around continuous full-dose treatment, but real-world endocrinology practice has converged on a few patterns. A maintenance dose, often a lower dose than the full weight-loss dose, holds weight stable for many people with fewer side effects. It is loosely analogous to how blood pressure medication is used long-term: stay on the dose that maintains the effect.

Restarting after a clean stop also works for many people. Pharmacologically, semaglutide and tirzepatide reach steady state again over roughly four to six weeks, and many people see appetite suppression return, though sometimes a notch weaker than the first round. Insurance coverage, side-effect history, and how you tolerated the original titration all factor in.

What tends to work least well is unstructured cycling, stopping cold, regaining, restarting, regaining again, on repeat. The choice between restarting and a maintenance dose belongs with your prescriber, ideally with weight, protein, and habit data from the months around your stop in front of them.

The maintenance work is largely the same whether you stop, drop to a maintenance dose, or cycle. A common approach is a protein target in the range of 0.8 to 1.0 grams per pound of bodyweight per day, spread across three or four meals. Strength training a couple of times a week, full body, focused on compound movements. Weighing on the same scale at the same time and watching the seven-day rolling average instead of the daily number. Aiming for seven or more hours of sleep. Steady hydration through the day. These are general wellness habits, not a prescription, and worth tailoring with your clinician.

This is the same stack covered in the keep weight off after GLP-1 guide, for a reason. The habits that help hold a loss are similar whether the medication is in your system, at a lower dose, or gone entirely. Phaze tracks each of these on one screen, so the stack stays visible even on the days you do not feel like looking.

Phaze's Taper Coach is built for this window. It looks at your logged weight, hunger, protein, and sleep and surfaces a quiet, plain-language nudge when one of them turns. Because those numbers live on one screen, it is easier to connect a rising weight now to a protein dip or a few short nights from a couple of weeks ago, instead of reading each as a separate problem. The taper warnings are gentle prompts, not commands, and they are there to inform your own choices, not to adjust your medication. Phaze is local-first: your daily logs stay on your iPhone, and medical entries like doses, side effects, injection sites, and notes are encrypted with AES-256-GCM in the Apple Keychain, with optional encrypted iCloud backup.

For the longer arc, the Phaze Taper Coach feature page walks through the pattern checks, the taper warnings, and the PDF report you can generate to bring to your prescriber. Pair it with the Phaze Lab Tracker so your fasting glucose and lipid trends sit next to your weight and protein, in one place. The point is not to replace your doctor. It is to make the next conversation a much better one.

A few questions are worth bringing into the appointment when you are considering stopping. First, what is the right step-down schedule for me, given my dose, how long I have been on it, and my other conditions. There is no universal answer, and your prescriber's recommendation matters more than any internet protocol. Second, what is the trigger to come back on, or to drop to a maintenance dose. A weight threshold, a glucose drift, a return of food noise, or an A1C number, getting that written down before you stop turns a vague intention into a real plan. Third, what bloodwork is worth running during the first six months off, so you can see whether the metabolic gains are holding.

Bring your weight, protein, and habit data into the visit. A clinician with a few months of trend data has more to work with than one looking at a single in-clinic weight, and the time saved on review is time spent on the actual decision. The deeper guide on keeping weight off after stopping GLP-1 covers the maintenance plan in more depth, and is worth reading before your appointment, not after.